杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/13 | 1,778 | 1,786 | 1,771 | 1,772 | -6 | -0.3% | 69,000 |
2021/10/12 | 1,788 | 1,793 | 1,773 | 1,778 | -21 | -1.2% | 87,300 |
2021/10/11 | 1,782 | 1,799 | 1,775 | 1,799 | +17 | +1% | 92,500 |
2021/10/08 | 1,774 | 1,792 | 1,771 | 1,782 | +7 | +0.4% | 130,900 |
2021/10/07 | 1,760 | 1,784 | 1,760 | 1,775 | +4 | +0.2% | 74,700 |
2021/10/06 | 1,759 | 1,777 | 1,750 | 1,771 | +13 | +0.7% | 84,400 |
2021/10/05 | 1,766 | 1,772 | 1,748 | 1,758 | -20 | -1.1% | 98,600 |
2021/10/04 | 1,764 | 1,779 | 1,757 | 1,778 | +19 | +1.1% | 71,200 |
2021/10/01 | 1,768 | 1,776 | 1,751 | 1,759 | -22 | -1.2% | 81,200 |
2021/09/30 | 1,779 | 1,799 | 1,779 | 1,781 | +5 | +0.3% | 69,500 |
2021/09/29 | 1,786 | 1,786 | 1,763 | 1,776 | -43 | -2.4% | 107,500 |
2021/09/28 | 1,826 | 1,826 | 1,815 | 1,819 | -7 | -0.4% | 95,200 |
2021/09/27 | 1,860 | 1,860 | 1,825 | 1,826 | -40 | -2.1% | 90,800 |
2021/09/24 | 1,883 | 1,883 | 1,863 | 1,866 | +20 | +1.1% | 112,800 |
2021/09/22 | 1,857 | 1,857 | 1,844 | 1,846 | -16 | -0.9% | 88,600 |
2021/09/21 | 1,876 | 1,886 | 1,862 | 1,862 | -26 | -1.4% | 90,500 |
2021/09/17 | 1,892 | 1,895 | 1,882 | 1,888 | +1 | +0.1% | 131,400 |
2021/09/16 | 1,886 | 1,893 | 1,876 | 1,887 | +3 | +0.2% | 133,800 |
2021/09/15 | 1,883 | 1,890 | 1,879 | 1,884 | -16 | -0.8% | 63,200 |
2021/09/14 | 1,901 | 1,906 | 1,885 | 1,900 | -1 | -0.1% | 100,300 |
2021/09/13 | 1,879 | 1,901 | 1,867 | 1,901 | +20 | +1.1% | 77,600 |
2021/09/10 | 1,861 | 1,881 | 1,860 | 1,881 | +15 | +0.8% | 116,700 |
2021/09/09 | 1,866 | 1,877 | 1,860 | 1,866 | -5 | -0.3% | 60,500 |
2021/09/08 | 1,884 | 1,889 | 1,863 | 1,871 | -9 | -0.5% | 89,100 |
2021/09/07 | 1,878 | 1,885 | 1,870 | 1,880 | +14 | +0.8% | 98,800 |
2021/09/06 | 1,860 | 1,869 | 1,850 | 1,866 | -4 | -0.2% | 96,000 |
2021/09/03 | 1,850 | 1,873 | 1,846 | 1,870 | +29 | +1.6% | 102,900 |
2021/09/02 | 1,837 | 1,851 | 1,830 | 1,841 | +1 | +0.1% | 97,000 |
2021/09/01 | 1,830 | 1,843 | 1,821 | 1,840 | +17 | +0.9% | 81,700 |
2021/08/31 | 1,850 | 1,851 | 1,819 | 1,823 | -31 | -1.7% | 106,300 |
2021/08/30 | 1,832 | 1,854 | 1,828 | 1,854 | +27 | +1.5% | 77,500 |
2021/08/27 | 1,812 | 1,829 | 1,802 | 1,827 | +10 | +0.6% | 80,800 |
2021/08/26 | 1,827 | 1,827 | 1,810 | 1,817 | -10 | -0.5% | 68,100 |
2021/08/25 | 1,848 | 1,848 | 1,821 | 1,827 | -11 | -0.6% | 93,600 |
2021/08/24 | 1,843 | 1,853 | 1,833 | 1,838 | -15 | -0.8% | 104,400 |
2021/08/23 | 1,848 | 1,858 | 1,839 | 1,853 | +20 | +1.1% | 100,600 |
2021/08/20 | 1,844 | 1,849 | 1,828 | 1,833 | -9 | -0.5% | 116,600 |
2021/08/19 | 1,833 | 1,849 | 1,827 | 1,842 | +9 | +0.5% | 94,100 |
2021/08/18 | 1,822 | 1,838 | 1,819 | 1,833 | +14 | +0.8% | 58,400 |
2021/08/17 | 1,824 | 1,830 | 1,814 | 1,819 | +4 | +0.2% | 63,600 |
2021/08/16 | 1,826 | 1,826 | 1,802 | 1,815 | -12 | -0.7% | 61,200 |
2021/08/13 | 1,808 | 1,827 | 1,802 | 1,827 | +21 | +1.2% | 66,600 |
2021/08/12 | 1,811 | 1,814 | 1,801 | 1,806 | +3 | +0.2% | 52,400 |
2021/08/11 | 1,800 | 1,807 | 1,791 | 1,803 | +13 | +0.7% | 103,500 |
2021/08/10 | 1,771 | 1,790 | 1,771 | 1,790 | +17 | +1% | 78,200 |
2021/08/06 | 1,778 | 1,789 | 1,764 | 1,773 | -2 | -0.1% | 82,400 |
2021/08/05 | 1,751 | 1,792 | 1,746 | 1,775 | +20 | +1.1% | 85,600 |
2021/08/04 | 1,750 | 1,766 | 1,731 | 1,755 | -45 | -2.5% | 157,700 |
2021/08/03 | 1,818 | 1,818 | 1,796 | 1,800 | -9 | -0.5% | 31,600 |
2021/08/02 | 1,784 | 1,811 | 1,777 | 1,809 | +38 | +2.1% | 82,600 |
851~
900
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム